Update from Alcobra on Recent FDA Communications
07 oct. 2016 08h48 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study
28 sept. 2016 20h01 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update
30 août 2016 07h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30
15 août 2016 08h00 HE
|
Alcobra Ltd.
Tel Aviv, Israel, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome
19 juil. 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, July 19, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
05 juil. 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, July 05, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Ltd. to Participate in Upcoming Investment Conferences
01 juin 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, June 01, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update
16 mai 2016 08h00 HE
|
Alcobra Ltd.
Conference Call & Webcast May 16th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, May 16, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16
04 mai 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, May 04, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Upcoming Investment Conferences
01 mars 2016 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, March 01, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...